Quarterly Reports :: Ligand Pharmaceuticals Incorporated (LGND)

Date	Form	Description	Docs	XBRL	Pages
05/10/11	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.23 EX-31.1 EX-31.2 EX-32.1 EX-32.2			107
11/09/10	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2			93
08/05/10	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2			71
05/05/10	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			50
11/09/09	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.323 EX-10.331 EX-31.1 EX-31.2 EX-32.1 EX-32.2			63
08/04/09	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.321 EX-10.322 EX-31.1 EX-31.2 EX-32.1 EX-32.2			72
05/11/09	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.318 EX-10.319 EX-10.320 EX-31.1 EX-31.2 EX-32.1 EX-32.2			108
11/07/08	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.316 EX-31.1 EX-31.2 EX-32.1 EX-32.2			61
08/05/08	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			50
05/08/08	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			50